Jeremy Murray

Jeremy Murray has over two decades of experience in the pharmaceutical industry. Jeremy started their career at Chiron/Novartis in 2002 as a Scientist/Principal Scientist. Jeremy then moved to Novartis NIBR in 2006 as a Research Investigator II. In 2008, Jeremy joined Genentech where they held various roles, including Scientist & Group Leader and Senior Scientist & Group Leader, until 2022. Currently, they are working at Exelixis as a Sr Principal Scientist & Group Leader.

Jeremy Murray has a PhD in Biochemistry and Structural Molecular Biology from the University of Leeds. Jeremy completed their post-doctoral research in Biophysics & Biochemistry at Yale University from 1999 to 2022. Additionally, they attended the University of California, Berkeley for Project Management, but no specific dates were provided.